Back to 
Royal Bank of Canada
Royal Bank of CanadaKYNB
5 quarters
Position history for Royal Bank of Canada's holdings in Kyntra Bio, Inc.
Yes. Royal Bank of Canada holds 138 shares of KYNB (Kyntra Bio), worth $1,000, as of its Q2 2026 13F filing. It increased the position by 1 shares (+0.7%) from Q1 2026. Royal Bank of Canada has held KYNB in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$1,000
Current Shares
138
Total Value Change
$0
Total Shares Change
+1
Quarter-by-Quarter History
Other major holders of KYNB: Vanguard Group Inc., Vanguard Capital Management LLC, BlackRock, Inc.